?5 integrin up-regulation in brain-derived neurotrophic factor promotes cell motility in human chondrosarcoma.
Ontology highlight
ABSTRACT: Chondrosarcoma is a primary malignant bone cancer, with a potent capacity to invade locally and cause distant metastasis; it has a poor prognosis and shows a predilection for metastasis to the lungs. Brain derived neurotrophic factor (BDNF) is a small-molecule protein from the neurotrophin family of growth factors that is associated with the disease status and outcomes of cancers. However, the effect of BDNF on migration activity in human chondrosarcoma cells is mostly unknown. Here, we found that human chondrosarcoma tissues showed significant expression of BDNF, which was higher than that in normal cartilage and primary chondrocytes. We also found that BDNF increased the migration and expression of ?5 integrin in human chondrosarcoma cells. In addition, knockdown of BDNF expression markedly inhibited migratory activity. BDNF-mediated migration and ?5 integrin up-regulation were attenuated by antibody, inhibitor, or siRNA against the TrkB receptor. Pretreatment of chondrosarcoma cells with PI3K, Akt, and NF-?B inhibitors or mutants also abolished BDNF-promoted migration and integrin expression. The PI3K, Akt, and NF-?B signaling pathway was activated after BDNF treatment. Taken together, our results indicate that BDNF enhances the migration of chondrosarcoma by increasing ?5 integrin expression through a signal transduction pathway that involves the TrkB receptor, PI3K, Akt, and NF-?B. BDNF thus represents a promising new target for treating chondrosarcoma metastasis.
SUBMITTER: Lin CY
PROVIDER: S-EPMC3706611 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA